AARTIPHARM — Aarti Pharmalabs Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapHigh Flyer

Annual income statement for Aarti Pharmalabs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Interim Report	Interim Report	ARS	ARS	ARS
Standards:	—	—	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	0	11,999	19,452	18,526	21,151
Cost of Revenue
Gross Profit	—	4,748	7,755	8,319	9,872
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	0.046	8,793	16,653	15,398	17,376
Operating Profit	-0.046	3,206	2,799	3,128	3,775
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-0.046	1,554	2,608	3,005	3,607
Provision for Income Taxes
Net Income After Taxes	-0.046	1,223	1,935	2,169	2,724
Net Income Before Extraordinary Items
Net Income	-0.046	1,223	1,935	2,169	2,724
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-0.046	1,223	1,935	2,169	2,724
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.001	27	21.4	23.9	30.1
Dividends per Share